Structure of complement fragment C3b-factor H and implications for host protection by complement regulators

Nature Immunology

Volumn 10, Issue 7, 2009, Pages 728-733

  Wu, Jin ^a   Wu, You Qiang ^b   Ricklin, Daniel ^b   Janssen, Bert J C ^a   Lambris, John D ^b   Gros, Piet ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I;

ARTICLE; BINDING COMPETITION; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION; HOST RESISTANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STRUCTURE;

BINDING SITES; COMPLEMENT C3B; COMPLEMENT FACTOR H; CRYSTALLOGRAPHY, X-RAY; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 67649230210     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1755     Document Type: Article

References (50)

1. Schmidt, C.Q., Herbert, A.P., Hocking, H.G., Uhrin, D. & Barlow, P.N. Translational mini-review series on complement factor H: Structural and functional correlations for factor H. Clin. Exp. Immunol. 151 14-24 (2008).
2. Liszewski, M.K., Farries, T.C., Lublin, D.M., Rooney, I.A. & Atkinson, J.P. Control of the complement system. Adv. Immunol. 61, 201-283 (1996).
3. Prosser, B.E. et al. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 204, 2277-2283 (2007).
4. Meri, S. Loss of self-control in the complement system and innate autoreactivity. Ann. NY Acad. Sci. 1109, 93-105 (2007).
5. de Cordoba, S.R. & de Jorge, E.G. Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151, 1-13 (2008).
6. Lambris, J.D., Ricklin, D. & Geisbrecht, B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6, 132-142 (2008).
7. Schneider, M.C. et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458, 890-893 (2009).
8. Ricklin, D. & Lambris, J.D. Complement-targeted therapeutics. Nat. Biotechnol. 25, 1265-1275 (2007).
9. Noris, M. & Remuzzi, G. Translational mini-review series on complement factor H: Therapies of renal diseases associated with complement factor H abnormalities: Atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin. Exp. Immunol. 151, 199-209 (2008).
10. Gordon, D.L., Kaufman, R.M., Blackmore, T.K., Kwong, J. & Lublin, D.M. Identification of complement regulatory domains in human factor H. J. Immunol. 155, 348-356 (1995).
11. Schmidt, C.Q. et al. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 181, 2610-2619 (2008).
12. Hocking, H.G. et al. Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J. Biol. Chem. 283, 9475-9487 (2008).
13. Okemefuna, A.I. et al. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J. Mol. Biol. 375, 80-101 (2008).
14. Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D. & Gros, P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213-216 (2006).
15. Wiesmann, C. et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444 217-220 (2006).
16. Becherer, J.D., Alsenz, J., Esparza, I., Hack, C.E. & Lambris, J.D. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B. Biochemistry 31, 1787-1794 (1992).
17. Lambris, J.D. et al. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156, 4821-4832 (1996).
18. Oran, A.E. & Isenman, D.E. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274, 5120-5130 (1999).
19. Janssen, B.J. et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511 (2005).
20. Gros, P., Milder, F.J. & Janssen, B.J. Complement driven by conformational changes. Nat. Rev. Immunol. 8, 48-58 (2008).
21. Rooijakkers, S.H.M. et al. Structural and functional implications of the complement convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. advance online publication, doi:10.1038/ni.1756 (7 June 2009).
22. Hourcade, D.E., Mitchell, L., Kuttner-Kondo, L.A., Atkinson, J.P. & Medof, M.E. Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. J. Biol. Chem. 277, 1107-1112 (2002).
23. Lukacik, P. et al. Complement regulation at the molecular level: the structure of decay-accelerating factor. Proc. Natl. Acad. Sci. USA 101, 1279-1284 (2004).
24. Kuttner-Kondo, L. et al. Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. J. Biol. Chem. 282, 18552-18562 (2007).
25. Harris, C.L., Abbott, R.J., Smith, R.A., Morgan, B.P. & Lea, S.M. Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J. Biol. Chem. 280, 2569-2578 (2005).
26. Luo, B.H., Carman, C.V. & Springer, T.A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619-647 (2007).
27. Goicoechea de Jorge, E. et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc. Natl. Acad. Sci. USA 104, 240-245 (2007).
28. Sahu, A., Isaacs, S.N., Soulika, A.M. & Lambris, J.D. Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J. Immunol. 160, 5596-5604 (1998).
29. DiScipio, R.G. Ultrastructures and interactions of complement factors H and I. J. Immunol. 149, 2592-2599 (1992).
30. Yadav, V.N., Pyaram, K., Mullick, J. & Sahu, A. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J. Virol. 82, 3283-3294 (2008).
31. Fritzinger, D.C. et al. Functional characterization of human C3/ cobra venom factor hybrid proteins for therapeutic complement depletion. Dev. Comp. Immunol. 33, 105-116 (2009).
32. Licht, C. et al. Deletion of Lys224 in regulatory domain 4 of factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int. 70, 42-50 (2006).
33. Saunders, R.E., Goodship, T.H., Zipfel, P.F. & Perkins, S.J. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: Insights into the structural consequences of disease-associated mutations. Hum. Mutat. 27, 21-30 (2006).
34. Fremeaux-Bacchi, V. et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112 4948-4952 (2008).
35. Caprioli, J. et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum. Mol. Genet. 12, 3385-3395 (2003).
36. Hageman, G.S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102, 7227-7232 (2005).
37. Abrera-Abeleda, M.A. et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J. Med. Genet. 43, 582-589 (2006).
38. Kondo, N., Honda, S., Kuno, S. & Negi, A. Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. Ophthalmology 116, 304-310 (2009).
39. Dragon-Durey, M.A. et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J. Am. Soc. Nephrol. 15, 787-795 (2004).
40. Liszewski, M.K. et al. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 275, 37692-37701 (2000).
41. Coleman, H.R., Chan, C.C., Ferris, F.L. III & Chew, E.Y. Age-related macular degeneration. Lancet 372, 1835-1845 (2008).
42. Lambris, J.D., Dobson, N.J. & Ross, G.D. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J. Exp. Med. 152, 1625-1644 (1980).
43. Evans, P. Scaling and assessment of data quality. Acta Crystallographica Section D 62, 72-82 (2006).
44. McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
45. Stein, N. CHAINSAW: A program for mutating pdb files used as templates in molecular replacement. J. Appl. Crystallogr. 41, 641-643 (2008).
46. Bouma, B. et al. Adhesion mechanism of human b2-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 18, 5166-5174 (1999).
47. Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
48. Winn, M.D., Murshudov, G.N. & Papiz, M.Z. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 374, 300-321 (2003).
49. Adams, P.D. et al. PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (2002).
50. Alsenz, J., Lambris, J.D., Schulz, T.F. & Dierich, M.P. Localization of the complement- component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H. Biochem. J. 224, 389-398 (1984).